Publication

Byline

Location

US Patent Issued to GRUENENTHAL on Sept. 29 for "Substituted [1,2,4triazolo[4,3-aquinoxalines, dosage forms containing them, and methods of using them to treat or prevent pain and/or inflammation" (German, Belgian Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,240, issued on Sept. 29, was assigned to GRUENENTHAL GMBH (Germany). "Substituted [1,2,4triazolo[4,3-aquinoxalines, dosage forms containin... और पढ़ें


US Patent Issued to BIOGEN MA on Sept. 29 for "Compounds for targeting degradation of Bruton's tyrosine kinase" (Massachusetts Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,241, issued on Sept. 29, was assigned to BIOGEN MA INC. (Cambridge, Mass.). "Compounds for targeting degradation of Bruton's tyrosine kina... और पढ़ें


US Patent Issued to Studiengesellschaft Kohle gGmbH on Sept. 29 for "Process for the catalytic glycosylation of arenes" (German, Belgian Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,242, issued on Sept. 29, was assigned to Studiengesellschaft Kohle gGmbH (Muelheim, Germany). "Process for the catalytic glycosylation of ... और पढ़ें


US Patent Issued to Northwestern University on Sept. 29 for "Substituted heterocycles for treating cancer" (Illinois Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,243, issued on Sept. 29, was assigned to Northwestern University (Evanston, Ill.). "Substituted heterocycles for treating cancer" was inve... और पढ़ें


US Patent Issued to Merck Sharp & Dohme on Sept. 29 for "Synthesis of BTK inhibitor and intermediates thereof" (New Jersey, Massachusetts Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,244, issued on Sept. 29, was assigned to Merck Sharp & Dohme LLC (Rahway, N.J.). "Synthesis of BTK inhibitor and intermediates thereof" wa... और पढ़ें


US Patent Issued to Satellos Bioscience on Sept. 29 for "AP2 associated kinase 1 inhibitors and uses thereof" (Canadian Inventor)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,245, issued on Sept. 29, was assigned to Satellos Bioscience Inc. (Toronto). "AP2 associated kinase 1 inhibitors and uses thereof" was inv... और पढ़ें


US Patent Issued to WIGEN BIOMEDICINE TECHNOLOGY (SHANGHAI) on Sept. 29 for "Fused cyclic compound as Wee-1 inhibitor, preparation method therefor and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,246, issued on Sept. 29, was assigned to WIGEN BIOMEDICINE TECHNOLOGY (SHANGHAI) Co. LTD. (Shanghai). "Fused cyclic compound as Wee-1 inhi... और पढ़ें


US Patent Issued to MEIJI SEIKA PHARMA on Sept. 29 for "Method for producing benzoxazole derivative having bicyclic piperazine ring or salt thereof, and method for producing material thereof" (Japanese Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,247, issued on Sept. 29, was assigned to MEIJI SEIKA PHARMA Co. LTD. (Tokyo). "Method for producing benzoxazole derivative having bicyclic... और पढ़ें


US Patent Issued to Enanta Pharmaceuticals on Sept. 29 for "Processes for the preparation of substituted spirooxindole derivatives" (Massachusetts, New Jersey Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,248, issued on Sept. 29, was assigned to Enanta Pharmaceuticals Inc. (Watertown, Mass.). "Processes for the preparation of substituted spi... और पढ़ें


US Patent Issued to SJP Biotec on Sept. 29 for "EIF4A-inhibiting compounds and methods related thereto" (California Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,249, issued on Sept. 29, was assigned to SJP Biotec GmbH (Zurich, Switzerland). "EIF4A-inhibiting compounds and methods related thereto" w... और पढ़ें